Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
3'-Demethylnobiletin
Cat. No.:
0225LY-1462
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
3'-Demethylnobiletin offers chemopreventive protection against colon cancer by modulating cell-cycle arrest and inducing apoptosis in malignant cells.
Synonym:
112448-39-2; 3'-hydroxy-5,6,7,8,4'-pentamethoxyflavone; 2-(3-hydroxy-4-methoxyphenyl)-5,6,7,8-tetramethoxychromen-4-one; 3'-Hydroxy-4',5,6,7,8-pentamethoxyflavone; 4H-1-Benzopyran-4-one, 2-(3-hydroxy-4-methoxyphenyl)-5,6,7,8-tetramethoxy-
CAS No.:
112448-39-2
Compound CID:
183466
Formula:
C20H20O8
Formula Weight:
388.37
Specification
Relative Density:
1.304 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
3'-Demethylnobiletin can be used in metabolic research to investigate its potential in reducing lipid accumulation and improving metabolic health.
Library Information
Target:
LDL; Lipoxygenase; NF-κB; DNA/RNA synthesis; Integrin
Receptor:
AP-1; CD36; LDL; LOX; NF-κB
Pathways:
Cytoskeletal signaling; Metabolism; DNA damage/DNA repair; Cell cycle/Checkpoint; NF-κB
Plate Number:
AOCL-19
Plate Location:
g5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
80 mg/mL; 205.99 mM
